Amir Kazory

Dr. Amir Kazory


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2010 in The American Journal of Cardiology
Verified
Journal Article
Closed access
AKAmir Kazory
Amir Kazory

28 May 2013 in Clinical Kidney Journal
Verified
Journal Article
Open access
PDF file
AKAmir Kazory
Amir Kazory
RARavi Aiyer
Ravi Aiyer
Synthetic cannabinoids (SCs) have emerged as drugs of abuse with increasing popularity among young adults. The potential renal complication related to the abuse of SC was not recognized until recently. Here, we present a case of severe acute kidney injury (AKI) that developed after inhalation of SC in an otherwise healthy young patient. A kidney biopsy revealed severe acute tubular necrosis, and supportive management resulted in the recovery of the kidney function. Herein, we briefly summarize the only two previous reports (a total of 21 cases) on the association between SC abuse and renal dysfunction and identify the common aspects in all observations.

1 October 2013 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
AKAmir Kazory
Amir Kazory
Summary: Heart failure remains the leading cause of hospitalization in older patients and is considered a growing public health problem with a significant financial burden on the health care system. The suboptimal efficacy and safety profile of diuretic-based therapeutic regimens coupled with unsatisfactory results of the studies on novel pharmacologic agents have positioned ultrafiltration on the forefront as an appealing therapeutic option for patients with acute decompensated heart failure (ADHF). In recent years, substantial interest in the use of ultrafiltration has been generated due to the advent of dedicated portable devices and promising results of trials focusing both on mechanistic and clinical aspects of this therapeutic modality. This article briefly reviews the proposed benefits of ultrafiltration therapy in the setting of ADHF and summarizes the major findings of the currently available studies in this field. The results of more recent trials on cardiorenal syndrome that present a counterpoint to previous observations and highlight certain limitations of ultrafiltration therapy are then discussed, followed by identification of major challenges and unanswered questions that could potentially hinder its more widespread use. Future studies are warranted to shed light on less well characterized aspects of ultrafiltration therapy and to further define its role in ADHF and cardiorenal syndrome.

12 January 2006 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
AKAmir Kazory
Amir Kazory
KDKourosh Dibadj
Kourosh Dibadj
IWI. David Weiner
I. David Weiner
Sir, HIV-infected children have an immature immune system that is unable to control HIV-1 replication efficiently. 1 Furthermore, many children on highly active antiretroviral therapy (HAART) rapidly experience virological failure allowing the appearance of

16 April 2020 in Baylor University Medical Center Proceedings
Verified
Journal Article
Closed access
AKAmir Kazory
Amir Kazory
CRClaudio Ronco
Claudio Ronco
PMPeter A. McCullough
Peter A. McCullough
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread across the globe, and millions of people may be affected. While knowledge regarding epidemiologic features and diagnostic tools of coronavirus disease 2019 (COVID-19) is rapidly evolving, uncertainties surrounding various aspects of its optimal management strategies persist. A subset of these patients develop a more severe form of the disease characterized by expanding pulmonary lesions, sepsis, acute respiratory distress syndrome, and respiratory failure. Due to lack of data on treatment strategies specific to this subset of patients, currently available evidence on management of the critically ill needs to be extrapolated and customized to their clinical needs. The article calls attention to fluid stewardship in the critically ill with COVID-19 by judiciously applying the evidence-based resuscitation principles to their specific clinical features such as high rates of cardiac injury. As we await more data from treating these patients, this strategy is likely to help reduce potential complications.

1 December 2014 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
AKAmir Kazory
Amir Kazory
UEUri Elkayam
Uri Elkayam